Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors
Omid Fotouhi1,2, Hanna Kjellin3,4, Catharina Larsson1,2, Jamileh Hashemi1,2, Jorge Barriuso5,6, C. Christofer Juhlin1,2, Ming Lu1,2, Anders Höög1,2, Laura Guerra7, Ángela Lamarca8,6, Victoria Heredia-Soto6, Jan Zedenius4, Marta Mendiola6,9, Janne Lehtiö3,2, Magnus Kjellman4
1Cancer Center Karolinska (O.F., C.L., J.H., C.C.J., M.L., A.H.), Karolinska University Hospital, Stockholm, Sweden
2Departments of Oncology-Pathology (O.F., C.L., J.H., C.C.J., M.L., A.H., J.L.), Karolinska Institutet, Stockholm, Sweden
3Cancer Proteomics Mass Spectrometry (H.K., J.L.), Science for Life Laboratory, Stockholm, Sweden SE-171 76
4Molecular Medicine and Surgery (H.K., J.Z., M.K.), Karolinska Institutet, Stockholm, Sweden
5Faculty of Biology (J.B.), Medicine and Health, University of Manchester, M13 9PT, Manchester, United Kingdom
6Laboratory of Molecular Pathology and Therapeutic Targets, and Translational Oncology Research Group (J.B., A.L., V.H.S., M.M.), Instituto de Investigación, Madrid, Spain
7Department of Pathology (L.G.P.), Hospital Universitario La Paz 28046, Madrid, Spain
8Department of Medical Oncology (A.L.), The Christie NHS Trust, M20 4BX, Manchester, United Kingdom
9Molecular Pathology Section (M.M.), Instituto de Genética Médica, Hospital Universitario La Paz 28046, Madrid, Spain
Tóm tắt
Từ khóa
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Journal of Clinical Endocrinology and Metabolism
Tập 101 Số 10
3616-3627
Thông tin tác giả